The Royal Glamorgan Hospital, is a District General Hospital in Ynysmaerdy, Talbot Green, Rhondda Cynon Taf, South Wales. It is managed by the Cwm Taf Morgannwg University Health Board.

There are 570 beds in Royal Glamorgan Hospital.

During the past decade, Royal Glamorgan Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Glamorgan Hospital" #1 sponsor was "University of Leeds" with 2 trials, followed by "Aalborg University Hospital" with 1 trials sponsored, "Anglo Celtic Cooperative Oncology Group" with 1 trials sponsored, "Cancer Research UK" with 1 trials sponsored and "Cardiff and Vale University Health Board" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Glamorgan Hospital" #1 collaborator was "University of Oxford" with 2 trials as a collaborator, "Asociación Científica Pulmón y Ventilación Mecánica" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator and "Berry Consultants" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Royal Glamorgan Hospital" are "Breast Cancer" (3 trials), "Giant Cell Arteritis" (2 trials), "Abscess Anorectal" (1 trials), "Abscess; Anus" (1 trials) and "Acute Respiratory Insufficiency" (1 trials). Many other conditions were trialed in "Royal Glamorgan Hospital" in a lesser frequency.

Most popular intervention types in "Royal Glamorgan Hospital" are "Drug" (9 trials), "Procedure" (4 trials), "Other" (3 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "capecitabine" (2 trials), "cyclophosphamide" (2 trials), "ARB + DMX-200" (1 trials) and "AZD2014" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Glamorgan Hospital" are 14 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Royal Glamorgan Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Royal Glamorgan Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Glamorgan Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".